imatinib mesylate has been researched along with Dermatitis, Atopic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egusa, C; Harada, K; Ito, T; Maeda, T; Numata, T; Okubo, Y; Seshimo, H | 1 |
1 other study(ies) available for imatinib mesylate and Dermatitis, Atopic
| Article | Year |
|---|---|
Topical application of imatinib mesylate suppresses vitamin D3 analog-induced dermatitis in Balb/c mice.
Topics: Animals; Cholecalciferol; Cytokines; Dermatitis, Atopic; Evans Blue; Imatinib Mesylate; Interleukin-33; Interleukin-4; Keratinocytes; Mice; Mice, Inbred BALB C; Thymic Stromal Lymphopoietin; Tumor Necrosis Factor-alpha | 2023 |